These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25240975)

  • 21. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
    Rajpert-De Meyts E
    Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From gonocytes to testicular cancer: the role of impaired gonadal development.
    Rajpert-de Meyts E; Hoei-Hansen CE
    Ann N Y Acad Sci; 2007 Dec; 1120():168-80. PubMed ID: 18184914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis.
    Wünsch L; Holterhus PM; Wessel L; Hiort O
    BJU Int; 2012 Dec; 110(11 Pt C):E958-65. PubMed ID: 22540217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
    Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
    Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.
    Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW
    Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome.
    Schumacher V; Gueler B; Looijenga LH; Becker JU; Amann K; Engers R; Dotsch J; Stoop H; Schulz W; Royer-Pokora B
    Mol Reprod Dev; 2008 Sep; 75(9):1484-94. PubMed ID: 18271004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadal development and tumor formation at the crossroads of male and female sex determination.
    Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH
    Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.
    Pyle LC; Nathanson KL
    Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadoblastoma and selected other aspects of gonadal pathology in young patients with disorders of sex development.
    Ulbright TM; Young RH
    Semin Diagn Pathol; 2014 Sep; 31(5):427-40. PubMed ID: 25129544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
    Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
    Looijenga LH
    J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing the risk of germ cell tumourigenesis in disorders of sex development patients.
    Cools M; Looijenga LH; Wolffenbuttel KP; T'Sjoen G
    Endocr Dev; 2014; 27():185-96. PubMed ID: 25247655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
    Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
    J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of neoplastic changes in germ cells as a developmental aspect].
    Słowikowska-Hilczer J
    Pediatr Endocrinol Diabetes Metab; 2007; 13(1):37-42. PubMed ID: 17493405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germ cell cancer risk in DSD patients.
    Cools M
    Ann Endocrinol (Paris); 2014 May; 75(2):67-71. PubMed ID: 24786700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell lines.
    van der Zwan YG; Rijlaarsdam MA; Rossello FJ; Notini AJ; de Boer S; Watkins DN; Gillis AJ; Dorssers LC; White SJ; Looijenga LH
    PLoS One; 2014; 9(6):e98330. PubMed ID: 24887064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testicular germ cell tumors.
    Looijenga LH
    Pediatr Endocrinol Rev; 2014 Feb; 11 Suppl 2():251-62. PubMed ID: 24683949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Undifferentiated gonadal tissue, Y chromosome instability, and tumors in XY gonadal dysgenesis.
    Beaulieu Bergeron M; Lemieux N; Brochu P
    Pediatr Dev Pathol; 2011; 14(6):445-59. PubMed ID: 21692598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development.
    Kristensen DM; Sonne SB; Ottesen AM; Perrett RM; Nielsen JE; Almstrup K; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    Mol Cell Endocrinol; 2008 Jun; 288(1-2):111-8. PubMed ID: 18420341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads.
    Cools M; Boter M; van Gurp R; Stoop H; Poddighe P; Lau YF; Drop SL; Wolffenbuttel KP; Looijenga LH
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):184-92. PubMed ID: 17547684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.